La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Phibro Animal Health Gestione
Gestione criteri di controllo 4/4
Phibro Animal Health's CEO is Jack Bendheim, appointed in Jan 1988, has a tenure of 36.58 years. total yearly compensation is $2.94M, comprised of 77.2% salary and 22.8% bonuses, including company stock and options. directly owns 49.94% of the company’s shares, worth $365.07M. The average tenure of the management team and the board of directors is 6.8 years and 15.2 years respectively.
Informazioni chiave
Jack Bendheim
Amministratore delegato
US$2.9m
Compenso totale
| Percentuale dello stipendio del CEO | 77.2% |
| Mandato del CEO | 36.6yrs |
| Proprietà del CEO | 49.9% |
| Durata media del management | 6.8yrs |
| Durata media del Consiglio di amministrazione | 15.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12
Aug 15
New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)
May 14Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
May 11Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business
May 01Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher
Apr 30Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$13m |
| Dec 31 2023 | n/a | n/a | US$15m |
| Sep 30 2023 | n/a | n/a | US$21m |
| Jun 30 2023 | US$3m | US$2m | US$33m |
| Mar 31 2023 | n/a | n/a | US$29m |
| Dec 31 2022 | n/a | n/a | US$36m |
| Sep 30 2022 | n/a | n/a | US$46m |
| Jun 30 2022 | US$4m | US$2m | US$49m |
| Mar 31 2022 | n/a | n/a | US$59m |
| Dec 31 2021 | n/a | n/a | US$53m |
| Sep 30 2021 | n/a | n/a | US$49m |
| Jun 30 2021 | US$4m | US$2m | US$54m |
| Mar 31 2021 | n/a | n/a | US$43m |
| Dec 31 2020 | n/a | n/a | US$44m |
| Sep 30 2020 | n/a | n/a | US$43m |
| Jun 30 2020 | US$3m | US$2m | US$34m |
| Mar 31 2020 | n/a | n/a | US$37m |
| Dec 31 2019 | n/a | n/a | US$38m |
| Sep 30 2019 | n/a | n/a | US$41m |
| Jun 30 2019 | US$3m | US$2m | US$55m |
| Mar 31 2019 | n/a | n/a | US$68m |
| Dec 31 2018 | n/a | n/a | US$73m |
| Sep 30 2018 | n/a | n/a | US$65m |
| Jun 30 2018 | US$3m | US$2m | US$65m |
Compensazione vs Mercato: Jack's total compensation ($USD2.94M) is about average for companies of similar size in the US market ($USD3.30M).
Compensazione vs guadagni: Jack's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Jack Bendheim (77 yo)
36.6yrs
Mandato
US$2,938,899
Compensazione
Mr. Jack Clifford Bendheim has been the President and Chief Executive Officer of Phibro Animal Health Corporation since 1988 and March 2014, respectively and serves as its Chairman. Mr. Bendheim served as...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 36.6yrs | US$2.94m | 49.94% $ 365.1m | |
| Chief Operating Officer | 8.1yrs | US$778.80k | 0.074% $ 541.5k | |
| Executive VP of Corporate Strategy & Director | 10.4yrs | US$554.69k | Nessun dato | |
| President of North America Region | 5.3yrs | US$619.27k | Nessun dato | |
| Chief Financial Officer | less than a year | Nessun dato | Nessun dato | |
| Senior VP | 1.1yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Human Resources | 7.4yrs | Nessun dato | Nessun dato | |
| President of MACIE Region | no data | Nessun dato | Nessun dato | |
| President South America Region | 7.2yrs | Nessun dato | Nessun dato | |
| President of Asia Pacific Region | 1.3yrs | Nessun dato | Nessun dato | |
| President of PhibroChem and Ethanol Performance Group | no data | Nessun dato | Nessun dato | |
| VP of Finance & Treasurer | 6.4yrs | Nessun dato | Nessun dato |
6.8yrs
Durata media
55yo
Età media
Gestione esperta: PAHC's management team is seasoned and experienced (6.8 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Chairman | 40.6yrs | US$2.94m | 49.94% $ 365.1m | |
| Executive VP of Corporate Strategy & Director | 10.8yrs | US$554.69k | Nessun dato | |
| President of MACIE Region | 6yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 20.6yrs | US$60.00k | Nessun dato | |
| Independent Non Executive Director | 20.3yrs | US$40.00k | Nessun dato | |
| Independent Director | 14.1yrs | US$60.00k | 0.0025% $ 18.1k | |
| Independent Non-Executive Director | 16.3yrs | US$50.00k | 0.049% $ 361.0k | |
| Independent Director | 1.5yrs | US$22.50k | Nessun dato |
15.2yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: PAHC's board of directors are seasoned and experienced ( 15.2 years average tenure).